IGO (IGO) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
4 Jun, 2026Executive summary
FY24 was marked by significant market volatility, leadership renewal, portfolio shifts, and operational challenges, but also progress in safety and asset performance, with TRIFR reduced to 10.4, a 35% year-over-year reduction.
Greenbushes delivered 1.38Mt production at AUD 330/t cost, maintaining 85% EBITDA margins despite market volatility.
Nova and Forrestania generated AUD 331M free cash flow; Forrestania mining to cease soon, with closure and rehabilitation planned.
Major non-cash impairments of AUD 458M were recognized against nickel and exploration assets, streamlining the portfolio.
Corporate team and operating model reshaped, including workforce reductions and new executive appointments to prepare for the next strategic phase.
Financial highlights
Underlying NPAT reached AUD 319M for FY24, down 79% year-over-year; statutory NPAT dropped to AUD 3M.
Revenue declined 18% year-over-year to AUD 841M.
Underlying EBITDA was AUD 581M, down 71% year-over-year.
Net cash from operating activities was AUD 872M, with a year-end cash balance of AUD 468M and liquidity at AUD 1.19B.
Final dividend of AUD 0.26/share, total AUD 0.37/share for the year, equating to AUD 280M returned to shareholders.
Outlook and guidance
Strategy session scheduled for September 12 to detail future direction, with continued focus on battery materials (lithium, nickel, copper) and operational excellence.
FY25 guidance: Nova nickel production 16,000–18,000t, cash cost AUD 4.80–5.80/lb; Greenbushes spodumene production 1,350–1,550kt, cash cost AUD 320–380/t.
Exploration spend guided to AUD 50–60M in FY25, with a run rate below AUD 50M from FY26.
Latest events from IGO
- Net loss of $955M on 37% lower revenue, with impairments and market headwinds impacting results.IGO
H2 20254 Jun 2026 - Revenue and EBITDA surged, but Greenbushes guidance was lowered amid operational challenges.IGO
Q3 202624 Apr 2026 - Loss after tax improved to AUD 34 million, with stronger Nova EBITDA and cost discipline.IGO
H1 202610 Apr 2026 - AGM revealed major losses, board renewal, and a refocused strategy on battery materials.IGO
AGM 20253 Feb 2026 - Operational strength at Nova and Greenbushes drove higher EBITDA and strong cash flow.IGO
Q2 20263 Feb 2026 - Strong cash flow, safety gains, and resilient core asset performance in FY24.IGO
Q4 20242 Feb 2026 - Lithium-led growth, disciplined returns, and net zero by 2035 drive the refreshed strategy.IGO
Strategy Day 202420 Jan 2026 - Lower prices drove a $2.9M EBITDA loss and 39% revenue drop despite strong Greenbushes output.IGO
Q1 202518 Jan 2026 - Strong cash flow, leadership renewal, and lithium growth amid operational and governance challenges.IGO
AGM 202416 Jan 2026